Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Research to Prevent Blindness Unrestricted Grant 2026
Fechtner, R. (PI)
01/1/26 → 12/31/26
Project: Research
-
Research to Prevent Blindness Unrestricted Grant 2025
Fechtner, R. (PI)
01/1/25 → 12/31/26
Project: Research
-
Salary support/stipends for support staff
Fechtner, R. (PI) & Barker-Griffith, A. (PI)
Health Science Center Foundation at Syracuse
06/23/16 → 12/31/27
Project: Research
-
Clarifying the optimal application of SLT therapy (COAST)
Fechtner, R. (PI)
09/1/24 → 08/31/25
Project: Research
-
Research to Prevent Blindness Unrestricted Grant 2024
Fechtner, R. (PI)
01/1/24 → 12/31/25
Project: Research
-
A phase 3 adaptive dose selection trial of NCX 470, a nitric oxide-donating bimatoprost for open-angle glaucoma or ocular hypertension: The MONT BLANC study
Mansberger, S. L., Fechtner, R., Lopez, K. & Hubatsch, D., Dec 2024, In: Contemporary Clinical Trials. 147, 107730.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
A Randomized, Controlled Comparison of NCX 470, a Nitric Oxide-Donating Bimatoprost, and Latanoprost in Subjects with Open-Angle Glaucoma or Ocular Hypertension: The MONT BLANC Study
Fechtner, R., Mansberger, S., Branch, J., Mulaney, J., Ziebell, S., Lopez, K. & Hubatsch, D., Aug 2024, In: American Journal of Ophthalmology. 264, p. 66-74 9 p.Research output: Contribution to journal › Article › peer-review
7 Scopus citations -
Changes and Diseases of the Aging Eye
Abazaga, M. & Fechtner, R., Jan 1 2024, Geriatric Medicine: A Person Centered Evidence Based Approach, Fifth Edition. Springer International Publishing, p. 663-689 27 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
2 Scopus citations -
Settings and effectiveness of the revised probe compared to the original probe for micropulse transscleral cyclophotocoagulation
Hadjokas, N., Dosakayala, N., Alpert, S., Ganapathy, P. & Fechtner, R., Dec 2024, In: Lasers in Medical Science. 39, 1, 136.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
A Randomized, Controlled Comparison of NCX 470 (0.021%, 0.042%, and 0.065%) and Latanoprost 0.005% in Patients With Open-angle Glaucoma or Ocular Hypertension: The Dolomites Study
Walters, T. R., Kothe, A. C., Boyer, J. L., Usner, D. W., Lopez, K., Duquesroix, B., Fechtner, R. D. & Navratil, T., Jun 1 2022, In: Journal of Glaucoma. 31, 6, p. 382-391 10 p.Research output: Contribution to journal › Article › peer-review
Open Access15 Scopus citations